Aslan's new Chief Medical Officer Kenneth Kobayashi, M.D. (Aslan) () Singapore-based Aslan Pharmaceuticals is hitting go again on its stalled dermatitis study. Back in April, ASLAN004, the biotech's ...
The Street is making up its mind on May’s market newbies, and ASLAN PHARMACEUTICALS ADR REP 5 ORD (NASDAQ: ASLN) received its judgment Wednesday. Two analysts issued Buy ratings and one a Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results